1. Fitzmaurice C, Akinyemiju TF, Al Lami FH, et al.
JAMA Oncol. 2018 Nov 1;4(11):1553-1568.
2. Allemani C, Matsuda T, Di Carlo V, et al.
Lancet. 2018 Mar 17;391(10125):1023-1075.
3. Salimzadeh H, Delavari F, Sauvaget C, et al.
Annual Trends of Gastrointestinal Cancers Mortality in Iran During 1990-2015; NASBOD Study.
Arch Iran Med. 2018 Feb 1;21(2):46-55.
4. Salimzadeh H, Khabiri R, Khazaee-Pool M, et al.
Patient Educ Couns. 2018 Jun;101(6):1082-1087.
5. Mansori K, Mosavi-Jarrahi A, Ganbary Motlagh A, et al.
Exploring Spatial Patterns of Colorectal Cancer in Tehran City, Iran.
Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1099-1104.
6. Mansori K, Solaymani-Dodaran M, Mosavi-Jarrahi A, et al.
J Prev Med Public Health. 2018 Jan;51(1):33-40.
7. Salimzadeh H, Bishehsari F, Sauvaget C, et al.
Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.
Arch Iran Med. 2017 Dec 1;20(12):726-733.
8. Salimzadeh H, Bishehsari F, Sauvaget C, et al.
Colon cancer screening by fecal immunochemical testing in Iran.
Annals of Oncology, Volume 28, Issue suppl_5, Sep 2017, https://doi.org/10.1093/annonc/mdx383.002.
9. Majidi A, Majidi S, Salimzadeh S, et al.
Cancer Screening Awareness and Practice in a Middle Income Country; A Systematic Review from Iran.
Asian Pac J Cancer Prev. 2017 Dec 28;18(12):3187-3194.
10. Javadinasab H, Daroudi R, Salimzadeh H, et al.
Cost-effectiveness of Screening Colonoscopy in Iranian High Risk Population.
Arch Iran Med. 2017 Sep;20(9):564-571.
11. Majidi A, Salimzadeh H, Beiki O, et al.
Public Health. 2017 Mar;144:42-47.
12. Bastaminejad S, Taherikalani M, Ghanbari R, et al.
Iran Biomed J. 2017 Mar;21(2):106-13.
13. Vahdatimanesh Z, Zendehdel K, Kbari Sari AA, et al.
Economic burden of colorectal cancer in Iran in 2012.
Med J Islam Repub Iran. 2017 Dec 20;31:115.
14. Khorrami S, Zavaran Hosseini A, et al.
MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer cells.
Tumour Biol. 2017 May;39(5):1010428317698365.
15. Salimzadeh H, Bishehsari F, Delavari A, et al.
BMJ Open. 2016 Dec 20;6(12):e013833.
16. Salimzadeh H, Bishehsari F, Amani M, et al.
Int J Cancer. 2016 Nov 15;139(10):2243-51.
17. Salimzadeh H, Delavari A, Amani M, et al.
Annals of Oncology, Volume 27, Issue suppl_6, Oct 2016, 1340P.
18. Salimzadeh H, Delavari A, Majidi A, et al.
Su1046 Risk Awareness, and Cancer Knowledge in First Degree Relatives of Patients with Colon Cancer.
Gastroentology. Volume 150, Issue 4, Suppl_1, Apr 2016. Page S455.
19. Armengol G, Sarhadi VK, Ghanbari R, et al.
J Mol Diagn. 2016 Jul;18(4):471-9.
20. Ghanbari R, Mosakhani N, Sarhadi VK, et al.
Biomark Cancer. 2016 Jan 12;7(Suppl 1):39-48.
21. Salimzadeh H, Najafipour H, Mirzaiepour F, et al.
Addict Health. 2016 Winter;8(1):16-24.
22. Delavari A, Salimzadeh H, Bishehsari F, et al.
Middle East J Dig Dis. 2015 Oct;7(4):214-9.
23. Moossavi S, Salimzadeh H, Katoonizadeh A, et al.
Physicians' Knowledge and Attitude Towards Fecal Microbiota Transplant in Iran.
Middle East J Dig Dis. 2015 Jul;7:155-60.
24. Moossavi S, Bishehsari F, Ansari R, et al.
Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.
Middle East J Dig Dis. 2015 Jul;7:177-80.
25. Ghanbari R, Mosakhani N, Asadi J, at al.
Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma.
Iran J Cancer Prev. 2015 May;8(3):e2329.
26. Ghanbari R, Mosakhani N, Asadi J, et al.
Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.
Cancer Biomark. 2015;15(2):189-95.
27. Khorrami S, Zavaran Hosseini A, Mowla SJ, Malekzadeh R.
Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line.
Iran J Cancer Prev. 2015 Oct;8(5):e3446.
28. Delavari A, Bishehsari F, Salimzadeh H, et al.
BMC Gastroenterol. 2014 Nov 18;14:196.
29. Delavari A, Mardan F, Salimzadeh H, et al.
Characteristics of colorectal polyps and cancer; a retrospective review of colonoscopy data in iran.
Middle East J Dig Dis. 2014 Jul;6(3):144-50.
30. Bishehsari F.
Race in colorectal cancer screening strategies: a solid determinant factor or a "moving target"?
Gastroenterology. 2014 Dec;147(6):1440.
31. Bishehsari F, Mahdavinia M, Vacca M, et al.
World J Gastroenterol. 2014 May 28;20(20):6055-72.
32. Moossavi S.
The necessity for an Iranian gut microbiome initiative.
Middle East J Dig Dis. 2014 Apr;6(2):109-10.
33. Salimzadeh H, Eftekhar H, Delavari A, et al.
Psycho-social Determinants of Colorectal Cancer Screening in Iran.
Int J Prev Med. 2014 Feb;5(2):185-90.
34. Modirian M, Rahimzadeh S, Cheraghi Z, et al.
Quality evaluation of national cancer registry system in Iran: study protocol.
Arch Iran Med. 2014 Mar;17(3):193-7.
35. Salimzadeh H, Ardeshir Larijani F, et al.
Arch Iran Med. 2014 Jan;17(1):33-53.
36. Salimzadeh H, Eftekhar H, Majdzadeh R, et al.
J Behav Med. 2014 Oct;37(5):1019-29.
37. Moossavi S, Zhang H, Sun J, Rezaei N.
Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer.
Expert Rev Clin Immunol. 2013 May;9(5):409-22.
38. Moossavi S, Ansari R.
Intestinal stem cell imaging in colorectal cancer screening.
J Stem Cells Regen Med. 2013 Nov 15;9(2):37-9.
39. Mirzazadeh A, Salimzadeh H, Arabi M, et al.
Trends of Obesity in Iranian Adults from 1990s to late 2000s; a Systematic Review and Meta-analysis.
Middle East J Dig Dis. 2013 Jul;5(3):151-7.
40. Salimzadeh H, Delavari A, Montazeri A, et al.
Knowledge and practice of Iranians toward colorectal cancer, and barriers to screening.
Int J Prev Med. 2012 Jan;3(1):29-35.
41. Moossavi S, Bishehsari F.
Inflammation in sporadic colorectal cancer.
Arch Iran Med. 2012 Mar;15(3):166-70.
42. Esposito DL, Aru F, Lattanzio R, et al.
PLoS One. 2012;7(4):e36190.
43. Sohrabi S, Malekzadeh R, Ansari R, et al.
Squatting and risk of colorectal cancer:a case-control study.
Middle East J Dig Dis. 2012 Jan;4(1):23-7.
44. Salimzadeh H, Eftekhar H, Majdzadeh R, et al.
More than half of senior residents in Tehran have never heard about colorectal cancer screening. Asian Pac J Cancer Prev. 2011;12(11):2851-6.
45. Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R.
Epidemiology and molecular genetics of colorectal cancer in iran: a review.
Arch Iran Med. 2009 Mar;12(2):161-9.
46. Mahdavinia M, Bishehsari F, Verginelli F, et al.
J Cell Physiol. 2008 Aug;216(2):543-50.
47. Bishehsari F, Mahdavinia M, Malekzadeh R, et al.
Ann Oncol. 2006 Jun;17 Suppl 7:vii91-6.
48. Ansari R, Mahdavinia M, Sadjadi A, et al.
Cancer Lett. 2006 Aug 18;240(1):143-7.
49. Mahdavinia M, Bishehsari F, Ansari R, et al.
Family history of colorectal cancer in Iran.
BMC Cancer. 2005 Sep 5;5:112.
50. Nasseri-Moghaddam S, Mohamadnejad M, Malekzadeh R, at al.
Images of interest Gastrointestinal: polypoid arteriovenous malformation of the colon. J
Gastroenterol Hepatol. 2004 Dec;19(12):1419.
51. Sadjadi A, Malekzadeh R, Derakhshan MH, et al.
Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran.
Int J Cancer. 2003 Oct 20;107(1):113-8.
52. Mohamadnejad M, Babai M, Bidari A, et al.
Adenocarcinoma of the colon associated with sarcoidosis.
MedGenMed. 2003 Mar 3;5(1):6.